This file photograph taken on May 20, 2020, shows a bottle and pills of Hydroxychloroquine as they sit on a counter at Rock Canyon Pharmacy in Provo, Utah. - AFP
UNITED NATIONS, July 4 (Reuters) - The World Health Organisation (WHO) said that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with Covid-19 after they failed to reduce mortality.
The setback came as the WHO also reported more than 200,000 new cases globally of the disease for the first time in a single day.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
